Share Price and Basic Stock Data
Last Updated: January 21, 2026, 10:38 pm
| PEG Ratio | 94.58 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ircon International Ltd, a prominent player in the engineering sector, reported a market capitalization of ₹14,467 Cr and a current share price of ₹154. The company has demonstrated a robust revenue trajectory, with sales increasing from ₹7,380 Cr in FY 2022 to ₹10,368 Cr in FY 2023, and projected to rise further to ₹12,514 Cr in FY 2024. The revenue from operations per share stood at ₹114.40 for FY 2025, showcasing the company’s ability to generate substantial income relative to its share price. Quarterly sales figures have shown variability, peaking at ₹3,781 Cr in March 2023, but subsequently declining to ₹2,987 Cr in September 2023. Despite fluctuations, the overall trend suggests resilience and a strong demand for its engineering services, particularly in infrastructure development projects. Ircon’s operational scale and strategic project execution have positioned it well to capitalize on the growing infrastructure needs in India, which is expected to drive future growth.
Profitability and Efficiency Metrics
Ircon International Ltd’s profitability metrics reflect a mixed performance but indicate solid operational health. The operating profit margin (OPM) for FY 2023 was reported at 7%, with an operating profit of ₹704 Cr. This margin is expected to maintain stability around 8% to 9% in the coming fiscal years. The return on equity (ROE) stood at 11.3%, while the return on capital employed (ROCE) was 11.6%, suggesting efficient use of equity and capital in generating profits. The company reported a net profit of ₹765 Cr in FY 2023, which rose to ₹930 Cr in FY 2024, highlighting its ability to improve profitability amidst rising operational costs. However, the interest coverage ratio (ICR) at 5.55x indicates a potential risk if debt levels continue to rise, as the company navigates its financing strategies amid increasing borrowings of ₹5,138 Cr. Overall, while Ircon demonstrates effective cost management, its profitability will be closely tied to maintaining operational efficiency in a competitive landscape.
Balance Sheet Strength and Financial Ratios
Ircon International Ltd’s balance sheet presents a mixed picture of financial health. The company’s total assets rose to ₹19,521 Cr as of FY 2025, supported by a reserves figure of ₹6,270 Cr. However, total borrowings have surged to ₹5,138 Cr, leading to a debt-to-equity ratio of 0.67, which is relatively high compared to industry standards. The current ratio stands at 1.59, indicating adequate liquidity to cover short-term obligations. The company’s book value per share has increased to ₹67.27, reflecting solid equity growth. Additionally, the cash conversion cycle (CCC) reported at -592 days demonstrates an efficient working capital management strategy, allowing Ircon to effectively manage its receivables and payables. This efficiency, alongside a strong interest coverage ratio, provides a buffer against potential financial strains, although the rising debt levels warrant close monitoring. The financial ratios suggest that while Ircon is well-positioned, it must navigate the challenges posed by its increasing leverage.
Shareholding Pattern and Investor Confidence
Ircon’s shareholding pattern illustrates a stable yet evolving investor landscape. As of September 2025, promoters hold a significant 65.17% stake, indicating strong insider confidence in the company’s future. Foreign institutional investors (FIIs) have gradually increased their stake to 4.61%, while domestic institutional investors (DIIs) hold 1.64%. The public shareholding stands at 28.29%, which has shown fluctuations but reflects a diverse investor base. The number of shareholders increased from 2,89,486 in December 2022 to 11,68,064 by September 2025, demonstrating growing retail interest. This increasing shareholder base is a positive indicator of market confidence, although the notable reduction in promoter shareholding from 73.18% in December 2022 could signal a strategic shift or dilution. Overall, the shareholding pattern suggests a balanced approach to investor engagement, fostering confidence in Ircon’s long-term prospects.
Outlook, Risks, and Final Insight
The outlook for Ircon International Ltd remains cautiously optimistic, underpinned by its robust project pipeline and strategic focus on infrastructure development. The company’s ability to maintain profitability amidst rising costs will be crucial, particularly given the increasing borrowings and potential interest rate fluctuations. Key strengths include its strong operational efficiency, evidenced by a negative cash conversion cycle, and a solid reserve base that supports ongoing projects. However, risks persist, particularly related to its rising debt levels and the dependency on government contracts, which can be subject to delays and policy changes. In conclusion, while Ircon is well-positioned to capitalize on India’s infrastructure boom, it must navigate these challenges effectively to sustain its growth trajectory and enhance shareholder value in the long run.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 196 Cr. | 577 | 1,028/540 | 15.6 | 218 | 0.52 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 24.9 Cr. | 83.0 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 6.17 Cr. | 14.2 | 16.4/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 8.01 Cr. | 13.0 | 16.0/10.3 | 4.68 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 38.3 Cr. | 0.41 | 6.09/0.40 | 4.60 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,542.00 Cr | 440.94 | 34.97 | 119.01 | 0.32% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,239 | 2,347 | 3,781 | 2,764 | 2,987 | 2,930 | 3,787 | 2,287 | 2,448 | 2,613 | 3,412 | 1,786 | 1,977 |
| Expenses | 2,039 | 2,190 | 3,598 | 2,513 | 2,771 | 2,671 | 3,470 | 2,037 | 2,247 | 2,481 | 3,158 | 1,586 | 1,836 |
| Operating Profit | 200 | 156 | 183 | 251 | 216 | 259 | 317 | 251 | 201 | 132 | 254 | 200 | 141 |
| OPM % | 9% | 7% | 5% | 9% | 7% | 9% | 8% | 11% | 8% | 5% | 7% | 11% | 7% |
| Other Income | 81 | 75 | 186 | 64 | 177 | 119 | 107 | 107 | 142 | 86 | 103 | 124 | 156 |
| Interest | 31 | 30 | 33 | 33 | 37 | 37 | 41 | 48 | 53 | 56 | 62 | 75 | 85 |
| Depreciation | 24 | 24 | 36 | 19 | 27 | 27 | 27 | 27 | 28 | 31 | 32 | 37 | 40 |
| Profit before tax | 226 | 178 | 301 | 263 | 328 | 314 | 356 | 282 | 262 | 132 | 263 | 212 | 172 |
| Tax % | 23% | -7% | 15% | 29% | 24% | 22% | 31% | 20% | 22% | 35% | 19% | 22% | 21% |
| Net Profit | 174 | 190 | 256 | 187 | 251 | 245 | 247 | 224 | 206 | 86 | 212 | 164 | 137 |
| EPS in Rs | 1.85 | 2.02 | 2.73 | 1.99 | 2.67 | 2.60 | 2.62 | 2.38 | 2.19 | 0.92 | 2.24 | 1.75 | 1.47 |
Last Updated: January 1, 2026, 6:16 am
Below is a detailed analysis of the quarterly data for Ircon International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,977.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,786.00 Cr. (Jun 2025) to 1,977.00 Cr., marking an increase of 191.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,836.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,586.00 Cr. (Jun 2025) to 1,836.00 Cr., marking an increase of 250.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 141.00 Cr.. The value appears to be declining and may need further review. It has decreased from 200.00 Cr. (Jun 2025) to 141.00 Cr., marking a decrease of 59.00 Cr..
- For OPM %, as of Sep 2025, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Jun 2025) to 7.00%, marking a decrease of 4.00%.
- For Other Income, as of Sep 2025, the value is 156.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Jun 2025) to 156.00 Cr., marking an increase of 32.00 Cr..
- For Interest, as of Sep 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 75.00 Cr. (Jun 2025) to 85.00 Cr., marking an increase of 10.00 Cr..
- For Depreciation, as of Sep 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 37.00 Cr. (Jun 2025) to 40.00 Cr., marking an increase of 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 172.00 Cr.. The value appears to be declining and may need further review. It has decreased from 212.00 Cr. (Jun 2025) to 172.00 Cr., marking a decrease of 40.00 Cr..
- For Tax %, as of Sep 2025, the value is 21.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Jun 2025) to 21.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 137.00 Cr.. The value appears to be declining and may need further review. It has decreased from 164.00 Cr. (Jun 2025) to 137.00 Cr., marking a decrease of 27.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.47. The value appears to be declining and may need further review. It has decreased from 1.75 (Jun 2025) to 1.47, marking a decrease of 0.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:10 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,897 | 3,038 | 2,493 | 3,067 | 4,024 | 4,798 | 5,391 | 5,342 | 7,380 | 10,368 | 12,514 | 10,760 | 9,788 |
| Expenses | 2,981 | 2,351 | 2,228 | 2,740 | 3,576 | 4,320 | 4,787 | 4,845 | 6,795 | 9,664 | 11,406 | 9,912 | 9,061 |
| Operating Profit | 917 | 687 | 264 | 328 | 448 | 479 | 604 | 497 | 585 | 704 | 1,108 | 847 | 727 |
| OPM % | 24% | 23% | 11% | 11% | 11% | 10% | 11% | 9% | 8% | 7% | 9% | 8% | 7% |
| Other Income | 253 | 264 | 421 | 313 | 189 | 212 | 178 | 196 | 261 | 413 | 403 | 431 | 469 |
| Interest | 39 | 33 | 43 | 59 | 65 | 15 | 28 | 23 | 62 | 119 | 149 | 221 | 278 |
| Depreciation | 34 | 57 | 31 | 27 | 16 | 52 | 83 | 92 | 95 | 107 | 100 | 118 | 140 |
| Profit before tax | 1,097 | 861 | 612 | 556 | 555 | 624 | 672 | 578 | 689 | 891 | 1,261 | 939 | 779 |
| Tax % | 32% | 32% | 36% | 31% | 26% | 28% | 28% | 32% | 14% | 14% | 26% | 22% | |
| Net Profit | 747 | 583 | 393 | 384 | 409 | 450 | 485 | 391 | 592 | 765 | 930 | 728 | 598 |
| EPS in Rs | 37.73 | 29.40 | 19.85 | 3.88 | 4.35 | 4.79 | 5.16 | 4.16 | 6.30 | 8.14 | 9.88 | 7.73 | 6.38 |
| Dividend Payout % | 24% | 31% | 43% | 96% | 47% | 45% | 46% | 36% | 40% | 37% | 31% | 34% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -21.95% | -32.59% | -2.29% | 6.51% | 10.02% | 7.78% | -19.38% | 51.41% | 29.22% | 21.57% | -21.72% |
| Change in YoY Net Profit Growth (%) | 0.00% | -10.64% | 30.30% | 8.80% | 3.51% | -2.25% | -27.16% | 70.79% | -22.18% | -7.65% | -43.29% |
Ircon International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| TTM: | -31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 31% |
| 3 Years: | 58% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 7:50 am
Balance Sheet
Last Updated: December 10, 2025, 2:52 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 99 | 94 | 94 | 94 | 94 | 188 | 188 | 188 | 188 | 188 |
| Reserves | 2,996 | 3,285 | 3,619 | 3,718 | 3,667 | 3,870 | 4,077 | 4,309 | 4,478 | 5,023 | 5,683 | 6,138 | 6,270 |
| Borrowings | 0 | 239 | 0 | 0 | 3,200 | 3,077 | 0 | 331 | 1,399 | 1,505 | 2,570 | 4,299 | 5,138 |
| Other Liabilities | 3,197 | 3,893 | 4,500 | 5,415 | 5,810 | 6,278 | 6,009 | 6,520 | 8,382 | 8,821 | 9,011 | 8,896 | 8,624 |
| Total Liabilities | 6,213 | 7,437 | 8,139 | 9,231 | 12,771 | 13,318 | 10,181 | 11,254 | 14,446 | 15,537 | 17,452 | 19,521 | 20,219 |
| Fixed Assets | 216 | 736 | 506 | 524 | 568 | 1,890 | 1,982 | 1,922 | 1,845 | 1,825 | 1,736 | 2,453 | 3,471 |
| CWIP | 48 | 30 | 75 | 549 | 964 | 55 | 30 | 13 | 36 | 19 | 549 | 976 | 620 |
| Investments | 434 | 496 | 487 | 781 | 784 | 809 | 803 | 850 | 971 | 1,049 | 1,553 | 1,296 | 1,874 |
| Other Assets | 5,515 | 6,174 | 7,070 | 7,378 | 10,455 | 10,565 | 7,366 | 8,468 | 11,594 | 12,644 | 13,614 | 14,796 | 14,254 |
| Total Assets | 6,213 | 7,437 | 8,139 | 9,231 | 12,771 | 13,318 | 10,181 | 11,254 | 14,446 | 15,537 | 17,452 | 19,521 | 20,219 |
Below is a detailed analysis of the balance sheet data for Ircon International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 188.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 188.00 Cr..
- For Reserves, as of Sep 2025, the value is 6,270.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,138.00 Cr. (Mar 2025) to 6,270.00 Cr., marking an increase of 132.00 Cr..
- For Borrowings, as of Sep 2025, the value is 5,138.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 4,299.00 Cr. (Mar 2025) to 5,138.00 Cr., marking an increase of 839.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 8,624.00 Cr.. The value appears to be improving (decreasing). It has decreased from 8,896.00 Cr. (Mar 2025) to 8,624.00 Cr., marking a decrease of 272.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 20,219.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19,521.00 Cr. (Mar 2025) to 20,219.00 Cr., marking an increase of 698.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,471.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,453.00 Cr. (Mar 2025) to 3,471.00 Cr., marking an increase of 1,018.00 Cr..
- For CWIP, as of Sep 2025, the value is 620.00 Cr.. The value appears to be declining and may need further review. It has decreased from 976.00 Cr. (Mar 2025) to 620.00 Cr., marking a decrease of 356.00 Cr..
- For Investments, as of Sep 2025, the value is 1,874.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,296.00 Cr. (Mar 2025) to 1,874.00 Cr., marking an increase of 578.00 Cr..
- For Other Assets, as of Sep 2025, the value is 14,254.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14,796.00 Cr. (Mar 2025) to 14,254.00 Cr., marking a decrease of 542.00 Cr..
- For Total Assets, as of Sep 2025, the value is 20,219.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,521.00 Cr. (Mar 2025) to 20,219.00 Cr., marking an increase of 698.00 Cr..
Notably, the Reserves (6,270.00 Cr.) exceed the Borrowings (5,138.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 917.00 | 448.00 | 264.00 | 328.00 | 445.00 | 476.00 | 604.00 | 166.00 | 584.00 | 703.00 | -1.00 | 843.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 72 | 75 | 56 | 61 | 51 | 37 | 43 | 34 | 30 | 23 | 45 |
| Inventory Days | 173 | 150 | 157 | 152 | 320 | 76 | 50 | |||||
| Days Payable | 822 | 428 | 406 | 550 | 588 | 477 | 687 | |||||
| Cash Conversion Cycle | -588 | 72 | -203 | -193 | -337 | 51 | -231 | -358 | 34 | 30 | 23 | -592 |
| Working Capital Days | -81 | -147 | -215 | -175 | -162 | -101 | -85 | -119 | -128 | -47 | -41 | -32 |
| ROCE % | 41% | 27% | 18% | 14% | 11% | 9% | 12% | 13% | 14% | 16% | 18% | 12% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Quant Quantamental Fund | 1,000,000 | 1.27 | 13.88 | 1,000,000 | 2025-04-22 17:25:30 | 0% |
| Quant Value Fund | 770,000 | 1.39 | 10.68 | 770,000 | 2025-04-22 17:25:30 | 0% |
| Nippon India Nifty Smallcap 250 Index Fund | 153,481 | 0.3 | 2.13 | 153,481 | 2025-04-22 17:25:30 | 0% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 96,362 | 0.3 | 1.34 | 96,362 | 2025-04-22 17:25:30 | 0% |
| SBI Nifty Smallcap 250 Index Fund | 70,721 | 0.3 | 0.98 | 70,721 | 2025-04-22 17:25:30 | 0% |
| Motilal Oswal Nifty 500 Index Fund | 10,530 | 0.03 | 0.15 | 10,530 | 2025-04-22 17:25:30 | 0% |
| Edelweiss Nifty Smallcap 250 Index Fund | 3,254 | 0.29 | 0.05 | 3,254 | 2025-04-22 17:25:30 | 0% |
| Groww Nifty Total Market Index Fund | 576 | 0.02 | 0.01 | 576 | 2025-04-22 17:25:30 | 0% |
| Motilal Oswal Nifty 500 ETF | 461 | 0.03 | 0.01 | 461 | 2025-04-22 17:25:30 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 7.73 | 9.88 | 8.14 | 6.30 | 4.16 |
| Diluted EPS (Rs.) | 7.73 | 9.88 | 8.14 | 6.30 | 4.16 |
| Cash EPS (Rs.) | 8.36 | 10.46 | 8.94 | 6.67 | 9.96 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 67.27 | 62.80 | 55.55 | 49.62 | 93.63 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 67.27 | 62.80 | 55.55 | 49.62 | 93.63 |
| Revenue From Operations / Share (Rs.) | 114.40 | 131.11 | 110.24 | 78.47 | 113.60 |
| PBDIT / Share (Rs.) | 12.93 | 15.56 | 11.54 | 8.43 | 14.42 |
| PBIT / Share (Rs.) | 11.68 | 14.50 | 10.39 | 7.42 | 12.46 |
| PBT / Share (Rs.) | 9.35 | 12.92 | 9.14 | 6.68 | 11.97 |
| Net Profit / Share (Rs.) | 7.10 | 9.39 | 7.80 | 5.66 | 8.00 |
| NP After MI And SOA / Share (Rs.) | 7.73 | 9.88 | 8.14 | 6.30 | 8.32 |
| PBDIT Margin (%) | 11.30 | 11.87 | 10.46 | 10.74 | 12.69 |
| PBIT Margin (%) | 10.20 | 11.05 | 9.42 | 9.45 | 10.96 |
| PBT Margin (%) | 8.17 | 9.85 | 8.29 | 8.51 | 10.53 |
| Net Profit Margin (%) | 6.20 | 7.16 | 7.07 | 7.21 | 7.04 |
| NP After MI And SOA Margin (%) | 6.76 | 7.53 | 7.38 | 8.02 | 7.32 |
| Return on Networth / Equity (%) | 11.49 | 15.83 | 14.68 | 12.69 | 8.88 |
| Return on Capital Employeed (%) | 8.93 | 13.20 | 11.81 | 10.37 | 10.71 |
| Return On Assets (%) | 3.72 | 5.32 | 4.92 | 4.10 | 3.47 |
| Long Term Debt / Equity (X) | 0.65 | 0.41 | 0.27 | 0.27 | 0.07 |
| Total Debt / Equity (X) | 0.67 | 0.43 | 0.28 | 0.29 | 0.07 |
| Asset Turnover Ratio (%) | 0.58 | 0.74 | 0.69 | 0.57 | 0.42 |
| Current Ratio (X) | 1.59 | 1.68 | 1.54 | 1.33 | 1.29 |
| Quick Ratio (X) | 1.57 | 1.65 | 1.51 | 1.29 | 1.27 |
| Inventory Turnover Ratio (X) | 65.55 | 2.38 | 1.61 | 2.61 | 1.67 |
| Dividend Payout Ratio (NP) (%) | 38.14 | 30.35 | 30.11 | 56.36 | 40.40 |
| Dividend Payout Ratio (CP) (%) | 32.82 | 27.39 | 26.40 | 48.56 | 32.70 |
| Earning Retention Ratio (%) | 61.86 | 69.65 | 69.89 | 43.64 | 59.60 |
| Cash Earning Retention Ratio (%) | 67.18 | 72.61 | 73.60 | 51.44 | 67.30 |
| Interest Coverage Ratio (X) | 5.55 | 9.86 | 9.19 | 11.52 | 29.10 |
| Interest Coverage Ratio (Post Tax) (X) | 4.05 | 6.95 | 7.21 | 8.74 | 17.15 |
| Enterprise Value (Cr.) | 14218.31 | 18205.56 | 1661.58 | -374.58 | 1020.31 |
| EV / Net Operating Revenue (X) | 1.32 | 1.48 | 0.16 | -0.05 | 0.19 |
| EV / EBITDA (X) | 11.69 | 12.44 | 1.53 | -0.47 | 1.50 |
| MarketCap / Net Operating Revenue (X) | 1.37 | 1.67 | 0.50 | 0.50 | 0.77 |
| Retention Ratios (%) | 61.85 | 69.64 | 69.88 | 43.63 | 59.59 |
| Price / BV (X) | 2.32 | 3.51 | 1.01 | 0.80 | 0.94 |
| Price / Net Operating Revenue (X) | 1.37 | 1.67 | 0.50 | 0.50 | 0.77 |
| EarningsYield | 0.04 | 0.04 | 0.14 | 0.15 | 0.09 |
After reviewing the key financial ratios for Ircon International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 9.88 (Mar 24) to 7.73, marking a decrease of 2.15.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 9.88 (Mar 24) to 7.73, marking a decrease of 2.15.
- For Cash EPS (Rs.), as of Mar 25, the value is 8.36. This value is within the healthy range. It has decreased from 10.46 (Mar 24) to 8.36, marking a decrease of 2.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 67.27. It has increased from 62.80 (Mar 24) to 67.27, marking an increase of 4.47.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 67.27. It has increased from 62.80 (Mar 24) to 67.27, marking an increase of 4.47.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 114.40. It has decreased from 131.11 (Mar 24) to 114.40, marking a decrease of 16.71.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.93. This value is within the healthy range. It has decreased from 15.56 (Mar 24) to 12.93, marking a decrease of 2.63.
- For PBIT / Share (Rs.), as of Mar 25, the value is 11.68. This value is within the healthy range. It has decreased from 14.50 (Mar 24) to 11.68, marking a decrease of 2.82.
- For PBT / Share (Rs.), as of Mar 25, the value is 9.35. This value is within the healthy range. It has decreased from 12.92 (Mar 24) to 9.35, marking a decrease of 3.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.10. This value is within the healthy range. It has decreased from 9.39 (Mar 24) to 7.10, marking a decrease of 2.29.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 9.88 (Mar 24) to 7.73, marking a decrease of 2.15.
- For PBDIT Margin (%), as of Mar 25, the value is 11.30. This value is within the healthy range. It has decreased from 11.87 (Mar 24) to 11.30, marking a decrease of 0.57.
- For PBIT Margin (%), as of Mar 25, the value is 10.20. This value is within the healthy range. It has decreased from 11.05 (Mar 24) to 10.20, marking a decrease of 0.85.
- For PBT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has decreased from 9.85 (Mar 24) to 8.17, marking a decrease of 1.68.
- For Net Profit Margin (%), as of Mar 25, the value is 6.20. This value is within the healthy range. It has decreased from 7.16 (Mar 24) to 6.20, marking a decrease of 0.96.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.76. This value is below the healthy minimum of 8. It has decreased from 7.53 (Mar 24) to 6.76, marking a decrease of 0.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.49. This value is below the healthy minimum of 15. It has decreased from 15.83 (Mar 24) to 11.49, marking a decrease of 4.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.93. This value is below the healthy minimum of 10. It has decreased from 13.20 (Mar 24) to 8.93, marking a decrease of 4.27.
- For Return On Assets (%), as of Mar 25, the value is 3.72. This value is below the healthy minimum of 5. It has decreased from 5.32 (Mar 24) to 3.72, marking a decrease of 1.60.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.41 (Mar 24) to 0.65, marking an increase of 0.24.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.67. This value is within the healthy range. It has increased from 0.43 (Mar 24) to 0.67, marking an increase of 0.24.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.58. It has decreased from 0.74 (Mar 24) to 0.58, marking a decrease of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 1.68 (Mar 24) to 1.59, marking a decrease of 0.09.
- For Quick Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.65 (Mar 24) to 1.57, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 65.55. This value exceeds the healthy maximum of 8. It has increased from 2.38 (Mar 24) to 65.55, marking an increase of 63.17.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 38.14. This value is within the healthy range. It has increased from 30.35 (Mar 24) to 38.14, marking an increase of 7.79.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 32.82. This value is within the healthy range. It has increased from 27.39 (Mar 24) to 32.82, marking an increase of 5.43.
- For Earning Retention Ratio (%), as of Mar 25, the value is 61.86. This value is within the healthy range. It has decreased from 69.65 (Mar 24) to 61.86, marking a decrease of 7.79.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 67.18. This value is within the healthy range. It has decreased from 72.61 (Mar 24) to 67.18, marking a decrease of 5.43.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.55. This value is within the healthy range. It has decreased from 9.86 (Mar 24) to 5.55, marking a decrease of 4.31.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.05. This value is within the healthy range. It has decreased from 6.95 (Mar 24) to 4.05, marking a decrease of 2.90.
- For Enterprise Value (Cr.), as of Mar 25, the value is 14,218.31. It has decreased from 18,205.56 (Mar 24) to 14,218.31, marking a decrease of 3,987.25.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.32. This value is within the healthy range. It has decreased from 1.48 (Mar 24) to 1.32, marking a decrease of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 11.69. This value is within the healthy range. It has decreased from 12.44 (Mar 24) to 11.69, marking a decrease of 0.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 1.67 (Mar 24) to 1.37, marking a decrease of 0.30.
- For Retention Ratios (%), as of Mar 25, the value is 61.85. This value is within the healthy range. It has decreased from 69.64 (Mar 24) to 61.85, marking a decrease of 7.79.
- For Price / BV (X), as of Mar 25, the value is 2.32. This value is within the healthy range. It has decreased from 3.51 (Mar 24) to 2.32, marking a decrease of 1.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 1.67 (Mar 24) to 1.37, marking a decrease of 0.30.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ircon International Ltd:
- Net Profit Margin: 6.2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.93% (Industry Average ROCE: 37.74%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.49% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.9 (Industry average Stock P/E: 34.97)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.67
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.2%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | Plot No. C-4, District Centre, New Delhi Delhi 110017 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Hari Mohan Gupta | Chairman & M.D & CEO |
| Mrs. Ragini Advani | Director - Finance |
| Mr. Ajit Kumar Mishra | Director - Works |
| Mr. Anand Kumar Singh | Director - Projects |
| Mr. Anand Bhatia | Part Time Official (Nominee) Director |
| Mr. Anupum Singh | Part Time Official (Nominee) Director |
| Mr. T Varadharajan | Ind. Part Time Non Official Director |
FAQ
What is the intrinsic value of Ircon International Ltd?
Ircon International Ltd's intrinsic value (as of 21 January 2026) is ₹151.38 which is 1.06% lower the current market price of ₹153.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹14,347 Cr. market cap, FY2025-2026 high/low of ₹230/134, reserves of ₹6,270 Cr, and liabilities of ₹20,219 Cr.
What is the Market Cap of Ircon International Ltd?
The Market Cap of Ircon International Ltd is 14,347 Cr..
What is the current Stock Price of Ircon International Ltd as on 21 January 2026?
The current stock price of Ircon International Ltd as on 21 January 2026 is ₹153.
What is the High / Low of Ircon International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ircon International Ltd stocks is ₹230/134.
What is the Stock P/E of Ircon International Ltd?
The Stock P/E of Ircon International Ltd is 23.9.
What is the Book Value of Ircon International Ltd?
The Book Value of Ircon International Ltd is 68.7.
What is the Dividend Yield of Ircon International Ltd?
The Dividend Yield of Ircon International Ltd is 1.73 %.
What is the ROCE of Ircon International Ltd?
The ROCE of Ircon International Ltd is 11.6 %.
What is the ROE of Ircon International Ltd?
The ROE of Ircon International Ltd is 11.3 %.
What is the Face Value of Ircon International Ltd?
The Face Value of Ircon International Ltd is 2.00.